Filing metadata

Accession number
0001567619-22-017847
Form type
Form 4
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
Sep 27, 2022
Reporting period
Sep 23, 2022
Description
Insider transaction

Explore SEC Filings Hub